Patient and tumor factors contributing to distant metastasis in well-differentiated thyroid cancer: a retrospective coho
- PDF / 667,197 Bytes
- 8 Pages / 595.276 x 790.866 pts Page_size
- 82 Downloads / 192 Views
(2020) 49:78
ORIGINAL RESEARCH ARTICLE
Open Access
Patient and tumor factors contributing to distant metastasis in well-differentiated thyroid cancer: a retrospective cohort study Usman Khan1* , Ayham Al Afif2, Abdullah Aldaihani2, Colin MacKay2, Matthew H. Rigby2, Murali Rajaraman3, Syed Ali Imran4, Martin J. Bullock5, S. Mark Taylor2, Jonathan R. B. Trites2 and Robert D. Hart6
Abstract Background: Distant metastasis in thyroid cancer significantly reduces survival in patients with well-differentiated thyroid carcinoma (WDTC). There is limited information available to clinicians regarding pathological features that confer a higher risk of distant metastasis (DM). This study aimed to identify patient and tumor factors that were associated with the development of DM over time in patients with WDTC. Methods: A retrospective cohort analysis of patients with WDTC (n = 584) at our institution was performed between 2007 and 2017. A total of 39 patients with DM and 529 patients with no DM (NDM) were included. Patient demographics, tumor characteristics and patient survival were compared between the DM and NDM groups using a univariate analysis. Multivariate Cox-proportional hazards model was used to evaluate the risk of developing distant metastasis over time. Kaplan-Meier analysis was used to compare survival between the DM and NDM groups. Results: Distant metastasis had a substantial impact on disease-specific survival (DSS) at 5 and 10-years in the DM group; 71.0% (SE 8.4%) and 46.9% (SE 11.6%) respectively, compared to 100% survival in the NDM group (p < 0.001). The DM group had significantly higher proportions of males, lymphovascular invasion (LVI), nodal metastasis (NM), large tumor size (TS), extrathyroidal extension (ETE), positive resection margins, multifocality, follicular thyroid cancer (FTC), tall cell variant of papillary thyroid cancer (PTC), and Hurthle cell carcinoma (HCC), when compared to the NDM group (p < 0.05). A TS ≥ 2 cm (Hazard Ratio (HR) 1.370), NM (HR 3.806) and FTC (HR 7.068) were associated with a significantly increased hazard of developing distant metastasis in patients with WDTC. Conclusions: TS ≥ 2 cm, NM and FTC are associated with a significantly increased propensity for developing DM in our cohort of WDTC patients. Keywords: Distant metastasis, Thyroid cancer, Well differentiated thyroid cancer, Metastatic thyroid cancer, Thyroid cancer survival
* Correspondence: [email protected] This paper was presented at the Canadian Society of Otolaryngology-Head and Neck Surgery Conference (CSOHNS) in Edmonton, Alberta, Canada on June 3rd, 2019. 1 Faculty of Medicine, Dalhousie University, 1459 Oxford Street, Halifax, Nova Scotia B3H 4R2, Canada Full list of author information is available at the end of the article
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(
Data Loading...
